KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Operating Leases (2019 - 2025)

Opko Health's Operating Leases history spans 7 years, with the latest figure at $36.8 million for Q4 2025.

  • For Q4 2025, Operating Leases fell 24.64% year-over-year to $36.8 million; the TTM value through Dec 2025 reached $36.8 million, down 24.64%, while the annual FY2025 figure was $36.8 million, 24.64% down from the prior year.
  • Operating Leases reached $36.8 million in Q4 2025 per OPK's latest filing, up from $36.3 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $64.8 million in Q3 2024 to a low of $24.9 million in Q2 2023.
  • Average Operating Leases over 5 years is $39.5 million, with a median of $37.1 million recorded in 2025.
  • Peak YoY movement for Operating Leases: soared 99.2% in 2024, then crashed 44.02% in 2025.
  • A 5-year view of Operating Leases shows it stood at $33.1 million in 2021, then fell by 15.51% to $28.0 million in 2022, then surged by 93.61% to $54.1 million in 2023, then dropped by 9.77% to $48.8 million in 2024, then fell by 24.64% to $36.8 million in 2025.
  • Per Business Quant, the three most recent readings for OPK's Operating Leases are $36.8 million (Q4 2025), $36.3 million (Q3 2025), and $37.3 million (Q2 2025).